Dapsone as first line therapy for bullous pemphigoid.

Dapsone as first line therapy for bullous pemphigoid.

In an open study, a total of 18 patients with proven bullous pemphigoid (16 new patients and two in relapse) were treated with a trial of dapsone (17 patients) or sulphonimide (one patient). Overall, eight patients were controlled on one of these agents as the sole treatment (44%). Six patients had...

Descripció completa

Dades bibliogràfiques
Autors principals:	Venning, V, Millard, P, Wojnarowska, F
Format:	Journal article
Idioma:	English
Publicat:	1989

Ítems similars

Induced bullous pemphigoid.
per: Venning, V, et al.
Publicat: (1995)

DIRECT IMMUNOFLUORESCENCE OF SUCTION BLISTERS IN BULLOUS AND CICATRICIAL PEMPHIGOID
per: Venning, V, et al.
Publicat: (1988)

The localization of the bullous pemphigoid and cicatricial pemphigoid antigens: direct and indirect immunofluorescence of suction blisters.
per: Venning, V, et al.
Publicat: (1989)

Human leukocyte antigen in bullous pemphigoid.
per: Venning, V, et al.
Publicat: (1991)

Bullous pemphigoid and autoimmunity.
per: Taylor, G, et al.
Publicat: (1993)

Bullous pemphigoid and diabetes mellitus
per: Taylor, G, et al.
Publicat: (1996)

Lack of predictive factors for the clinical course of bullous pemphigoid.
per: Venning, V, et al.
Publicat: (1992)

Oral and topical corticosteroids in bullous pemphigoid.
per: Ardern-Jones, MR, et al.
Publicat: (2002)

Oral and topical corticosteroids in bullous pemphigoid
per: Ardern-Jones, MR, et al.
Publicat: (2002)

Conjunctival involvement in cicatricial and bullous pemphigoid: a clinical and immunopathological study.
per: Frith, P, et al.
Publicat: (1989)

Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study.
per: Venning, V, et al.
Publicat: (1988)

Guidelines for the management of bullous pemphigoid.
per: Wojnarowska, F, et al.
Publicat: (2002)

OCULAR AND ORAL INVOLVEMENT IN BULLOUS AND CICATRICIAL PEMPHIGOID - A CLINICAL AND IMMUNOPATHOLOGICAL STUDY
per: Venning, V, et al.
Publicat: (1986)

HLA type in bullous pemphigoid, cicatricial pemphigoid and linear IgA disease.
per: Venning, V, et al.
Publicat: (1989)

The association of bullous pemphigoid and malignant disease: a case control study.
per: Venning, V, et al.
Publicat: (1990)

An immunohistochemical study of the distribution of plasminogen and plasminogen activators in bullous pemphigoid.
per: Venning, V, et al.
Publicat: (1993)

Bullous pemphigoid and associated autoimmune thrombocytopenia: two case reports.
per: Taylor, G, et al.
Publicat: (1993)

Concomitant bullous pemphigoid and neurological disease: an immunological association?
per: Taghipour, K, et al.
Publicat: (2008)

The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen.
per: Venning, V, et al.
Publicat: (1991)

Absence of expression of class II major histocompatibility complex determinants on keratinocytes in bullous pemphigoid.
per: Venning, V, et al.
Publicat: (1992)

Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature.
per: Kirtschig, G, et al.
Publicat: (1995)

Bullous pemphigoid evolving into cicatricial pemphigoid?
per: Banfield, C, et al.
Publicat: (1997)

Linear IgA dapsone responsive bullous dermatosis.
per: Wojnarowska, F
Publicat: (1980)

The association of HLA-DQ7 with bullous pemphigoid is restricted to men.
per: Banfield, C, et al.
Publicat: (1998)

Bullous pemphigoid: correlation of mucosal involvement and mucosal expression of autoantigens studied by indirect immunofluorescence and immunoblotting.
per: Kirtschig, G, et al.
Publicat: (1999)

Dapsone-responsive inflammatory dermatitis with features of subcorneal pustular dermatosis and bullous pemphigoid
per: Shilpa Ghatnekar, MS, et al.
Publicat: (2022-06-01)

Severe Infantile Bullous Pemphigoid Treated with Dapsone after Bridging with Systemic Glucocorticoid
per: Kenneth Thomsen, et al.
Publicat: (2019-06-01)

Determination of the optimum site for diagnostic biopsy for direct immunofluorescence in bullous pemphigoid.
per: Anstey, A, et al.
Publicat: (1990)

Treatments of choice for bullous pemphigoid.
per: Cooper, S, et al.
Publicat: (2002)

Interventions for bullous pemphigoid.
per: Khumalo, N, et al.
Publicat: (2003)

Interventions for bullous pemphigoid.
per: Khumalo, N, et al.
Publicat: (2005)

THE ROLE OF ALPHA-6 BETA-4-INTEGRINS IN BLISTER DEVELOPMENT IN BULLOUS PEMPHIGOID
per: Venning, V, et al.
Publicat: (1992)

The association of multiple sclerosis with bullous pemphigoid: is there a shared antigen response?
per: Taghipour, K, et al.
Publicat: (2012)

Flame figures in bullous pemphigoid.
per: Beer, T, et al.
Publicat: (1994)

The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study.
per: Taghipour, K, et al.
Publicat: (2010)

Lichen planus pemphigoides: its relationship to bullous pemphigoid.
per: Davis, A, et al.
Publicat: (1991)

The distribution of alpha 6 beta 4 integrins in lesional and non-lesional skin in bullous pemphigoid.
per: Venning, V, et al.
Publicat: (1992)

Dapsone – mechanism of action, safety of use and the role in the treatment of bullous pemphigoid according to current recommendations
per: Magdalena Żychowska, et al.
Publicat: (2016-05-01)

Bullous pemphigoid complicated by nonfatal necrotizing fasciitis.
per: Chamberlain, A, et al.
Publicat: (2003)

The incidence of bullous pemphigoid and other autoimmune bullous diseases in Oxfordshire, England
per: Reed, JR, et al.
Publicat: (2006)